Skip to content
AwardedSpainGoodsFramework agreement€281,041,200

Suministro de productos hemoderivados de uso terapéutico procedentes del fraccionamiento industrial del plasma humano proveniente del Sistema Nacional de Salud

Published
Published 5 September 2024
Deadline
Closed 4 October 2024

Overview

El objeto del presente Acuerdo Marco obedece a la necesidad de fijar las condiciones homogéneas y precios unitarios de los suministros de productos hemoderivados de uso terapéutico en el Sistema Nacional de Salud

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€281,041,200
Procedure
Open
Contract type
Framework agreement
Published
5 September 2024
Deadline
Closed
Classification (CPV)
Plasma extractsPharmaceutical products

Award outcome

Awarded value
€153
Award date
6 February 2025
Winner
  • INSTITUTO GRIFOLS, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    18 March 2025

  2. Contract Notice

    5 September 2024

Contracting authority

  • Dirección del Instituto Nacional de Gestión Sanitaria (INGESA)

    Procuring entity

    Madrid, Spain

    ID_PLATAFORMA: 10000440058861

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro de productos hemoderivados de uso terapéutico procedentes del fraccionamiento industrial del plasma humano proveniente del Sistema Nacional de Salud — won by INSTITUTO GRIFOLS, S.A. — Skim